We are live on ! Find out more
MET.PRE icon

MetLife Inc 5.625% Series E Preferred Stock
MET.PRE

2 hedge funds and large institutions have $7.95M invested in MetLife Inc 5.625% Series E Preferred Stock in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $7.56M → $7.95M (+$394K)

0.07% more ownership

Funds ownership: 0.86% → 0.94% (+0.07%)

33% less funds holding

Funds holding: 3 → 2 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CGH
Crossmark Global Holdings
Texas
+$729K

Top Sellers

Rank Fund Capital Flow
1
SC
Sierra Capital
Florida
-$101K
Name Holding Trade Value Shares
Change 		Change in
Stake
CGH
1
Crossmark Global Holdings
Texas
$7.63M +$729K +27,296 +10%
SAM
2
Selway Asset Management
$317K – – –
SC
3
Sierra Capital
Florida
– -$101K -3,700 Closed

MET.PRE Hedge Fund Activity: Q4 2021 in Review

2 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) for Q4 2021, worth a combined $7.95M — up 5.2% from $7.56M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of MET.PRE and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was Crossmark Global Holdings, adding an estimated $729K. The largest seller was Sierra Capital, exiting entirely with an estimated $101K sold.

  • 2 institutional investors held MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) as of Q4 2021, down from 3 in Q3 2021.
  • Funds reported $7.95M of MetLife Inc 5.625% Series E Preferred Stock stock for Q4 2021, up 5.2% quarter-over-quarter.
  • 0 funds opened new MetLife Inc 5.625% Series E Preferred Stock positions in Q4 2021 and 1 closed out, a net change of -1 holder.
  • The largest MetLife Inc 5.625% Series E Preferred Stock buyer in Q4 2021 was Crossmark Global Holdings, an estimated $729K added.
  • The largest MetLife Inc 5.625% Series E Preferred Stock seller in Q4 2021 was Sierra Capital, an estimated $101K sold.

Based on aggregated 13F filings for Q4 2021.